Stock A004720 PHARMGEN SCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News PharmGen Science, Inc.

Equities

A004720

KR7004720009

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
5,320 KRW +1.33% Intraday chart for PharmGen Science, Inc. +2.70% -14.19%
2023 PharmGen Science, Inc.(KOSE:A004720) dropped from S&P Global BMI Index CI
2023 PharmGen Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PharmGen Science, Inc.(KOSE:A004720) dropped from S&P Global BMI Index
CI
PharmGen Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
PharmGen Science Inc. announced that it has received KRW 20 billion in funding from Meritz Securities Co., Ltd.
CI
PharmGen Science Inc. announced that it expects to receive KRW 20 billion in funding from Meritz Securities Co., Ltd.
CI
PharmGen Science Inc. announced that it has received KRW 30 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited
CI
PharmGen Science Inc. announced that it expects to receive KRW 30 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited
CI
Wooridul Pharmaceutical Limited announced that it has received KRW 20 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited
CI
Wooridul Pharmaceutical Limited announced that it expects to receive KRW 20 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited
CI
Wooridul Pharmaceutical Limited(KOSE:A004720) added to S&P Global BMI Index
CI
Wooridul Pharmaceutical Limited cancelled the acquisition of 11.6% stake in Access Bio, Inc. from Youngho Choi.
CI
HD Fund signed a stock transfer agreement to acquire 6.4% stake in Wooridul Pharmaceutical Limited from Soo-Kyung Kim for KRW 12 billion.
CI
Access Bio, Inc. announced that it has received KRW 9.999999142 billion in funding from Wooridul Pharmaceutical Limited
CI
Wooridul Pharmaceutical Limited signed a contract to acquire 11.6% stake in Access Bio, Inc. from Youngho Choi for KRW 17 billion.
CI
Access Bio, Inc. announced that it expects to receive KRW 9.999999142 billion in funding from Wooridul Pharmaceutical Limited
CI
Wooridul Pharmaceutical Limited announced that it has received KRW 20 billion in funding from Choeun Mutual Savings Bank, Investment Arm, Hana Capital Co., Ltd., and other investors
CI
Wooridul Pharmaceutical Limited announced that it expects to receive KRW 20 billion in funding from Choeun Mutual Savings Bank, Investment Arm, Hana Capital Co., Ltd., and other investors.
CI
Miev Co., Ltd. announced that it has received KRW 1 billion in funding from Wooridul Pharmaceutical Limited
CI
Miev Co., Ltd. announced that it expects to receive KRW 1 billion in funding from Wooridul Pharmaceutical Limited
CI
Wooridul Pharmaceutical Limited(KOSE:A004720) dropped from S&P Global BMI Index
CI
Wooridul Pharmaceutical Limited(KOSE:A004720) added to S&P Global BMI Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A004720 Stock
  4. News PharmGen Science, Inc.